Orgenesis Inc (ORGS)
0.6099
-0.02
(-3.80%)
USD |
NASDAQ |
Jun 28, 16:00
0.6198
+0.01
(+1.62%)
Pre-Market: 20:00
Orgenesis Cash from Operations (Quarterly): -4.441M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -4.441M |
| December 31, 2023 | -0.502M |
| September 30, 2023 | -1.181M |
| June 30, 2023 | -5.914M |
| March 31, 2023 | -7.24M |
| December 31, 2022 | -10.76M |
| September 30, 2022 | -4.957M |
| June 30, 2022 | -6.414M |
| March 31, 2022 | -2.792M |
| December 31, 2021 | -2.464M |
| September 30, 2021 | -8.355M |
| June 30, 2021 | -11.50M |
| March 31, 2021 | -4.547M |
| December 31, 2020 | -45.23M |
| September 30, 2020 | -9.985M |
| June 30, 2020 | -9.141M |
| March 31, 2020 | -13.69M |
| December 31, 2019 | -2.706M |
| September 30, 2019 | -2.346M |
| June 30, 2019 | -3.657M |
| March 31, 2019 | -4.511M |
| November 30, 2018 | -3.209M |
| August 31, 2018 | -5.568M |
| May 31, 2018 | -4.814M |
| February 28, 2018 | -2.091M |
| Date | Value |
|---|---|
| November 30, 2017 | -0.397M |
| August 31, 2017 | -1.658M |
| May 31, 2017 | -2.177M |
| February 28, 2017 | 0.399M |
| November 30, 2016 | -0.606M |
| August 31, 2016 | -1.011M |
| May 31, 2016 | -0.825M |
| February 29, 2016 | -1.341M |
| November 30, 2015 | -0.661M |
| August 31, 2015 | -1.028M |
| May 31, 2015 | -0.376M |
| February 28, 2015 | -0.641M |
| November 30, 2014 | -0.3315M |
| August 31, 2014 | -0.1765M |
| May 31, 2014 | -0.421M |
| February 28, 2014 | -0.50M |
| November 30, 2013 | -0.4648M |
| August 31, 2013 | -0.5508M |
| May 31, 2013 | -0.5299M |
| February 28, 2013 | -0.4438M |
| November 30, 2012 | -0.3026M |
| August 31, 2012 | -0.3106M |
| May 31, 2012 | -0.3193M |
| February 29, 2012 | -0.1192M |
| November 30, 2011 | -0.0039M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-45.23M
Minimum
Dec 2020
-0.502M
Maximum
Dec 2023
-7.891M
Average
-5.436M
Median
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -3.654M |
| Theriva Biologics Inc | -4.881M |
| Oragenics Inc | -3.064M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.068M |
| Cash from Financing (Quarterly) | 3.614M |
| Free Cash Flow | -13.05M |
| Free Cash Flow Per Share (Quarterly) | -0.14 |
| Free Cash Flow to Equity (Quarterly) | -8.36M |
| Free Cash Flow to Firm (Quarterly) | -3.841M |
| Free Cash Flow Yield | -70.29% |